Intra-Cellular Therapies
ITCI
#1491
Rank
โ‚ฌ11.95 B
Marketcap
112,25ย โ‚ฌ
Share price
0.00%
Change (1 day)
72.57%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Last known market cap: โ‚ฌ11.95 Billion

As of December 2025 Intra-Cellular Therapies has a market cap of โ‚ฌ11.95 Billion. This makes Intra-Cellular Therapies the world's 1491th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ11.95 B38.32%
2024โ‚ฌ8.64 B38.64%
2023โ‚ฌ6.23 B33.45%
2022โ‚ฌ4.67 B24.1%
2021โ‚ฌ3.76 B80.98%
2020โ‚ฌ2.08 B22.36%
2019โ‚ฌ1.70 B211.05%
2018โ‚ฌ0.54 B-17.02%
2017โ‚ฌ0.65 B6.11%
2016โ‚ฌ0.62 B-70.76%
2015โ‚ฌ2.12 B395.93%
2014โ‚ฌ0.42 B33.4%
2013โ‚ฌ0.32 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
โ‚ฌ62.95 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ13.19 M-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.96 B-91.91%๐Ÿ‡บ๐Ÿ‡ธ USA